Faced with decreasing budgets and resources, healthcare providers require high quality rapid tests that deliver efficiency in every way, from performance to results. With the unique capability of enabling multiple results on one test device with just one drop of specimen, MedMira is delivering a new class of Multiplo rapid tests to its customers.
HIV and Hepatitis B (HBV) and C (HCV) are serious infectious diseases with similar modes of transmission, through blood and other body fluids. Approximately 33% of people living with HIV are co-infected with HCV. Co-infection is the leading non-AIDS cause of complications and death in HIV infected patients, with some research indicating that HCV progresses eight times faster in co-infected individuals rapidly developing into cirrhosis, liver failure, liver cancer or end-stage liver disease. Traditional testing methods involve individual tests for each virus with a turnaround time of several days up to a week. A fast, simple and economical, rapid test that delivers multiple results instantly can provide healthcare providers and their patients with critical information required to select the right follow-up and treatment plan.
MedMira has developed two multiple rapid tests to answer the increasing need for simultaneous detection of HIV and Hepatitis infections.